Other Clinical Trial - Supreme LMA & Proseal LMA in Prone Anesthetized

Clinical Trial Description

There is no significant difference about success rate of two device: efficacy and safety ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor)

Related Conditions & MeSH terms

Inadequate or Impaired Breathing Pattern or Ventilation

See also
Status	Clinical Trial	Phase
Completed	`NCT02823392` - Difficult Bag Mask Ventilation and Difficult Intubation in Children
Terminated	`NCT01241513` - Induced Changes in Ventilatory Responsiveness and Altitude Exposure	Phase 4
Completed	`NCT01322659` - Weaning Using Noninvasive Positive Pressure Ventilation by Means of Helmet in Patients With Acute Respiratory Failure	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT02823392 - Difficult Bag Mask Ventilation and Difficult Intubation in Children

Terminated

NCT01241513 - Induced Changes in Ventilatory Responsiveness and Altitude Exposure

Phase 4

Completed

NCT01322659 - Weaning Using Noninvasive Positive Pressure Ventilation by Means of Helmet in Patients With Acute Respiratory Failure

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01814306
Study type	Interventional
Source	Prince of Songkla University
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	October 2011
Completion date	June 2013

Supreme LMA and Proseal LMA in Prone Anesthetized Patient — SPLMA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms